| J2323 | Injection, natalizumab, 1 mg | 1 | 10 | 2,940 | $4,630 | $13.6M |
| J2350 | Injection, ocrelizumab, 1 mg | 1 | 10 | 60 | $18,390 | $4.9M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 460 | 480 | 1,350 | $110 | $1.7M |
| J0586 | Injection, abobotulinumtoxina, 5 units | 1 | 10 | 1,390 | $830 | $1.2M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1 | 40 | 260 | $510 | $684.9K |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 126 | 140 | 5,720 | $40 | $381.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 19 | 90 | 1,270 | $120 | $367.8K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 71 | 170 | 2,390 | $80 | $345K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 80 | 4,380 | 1,000 | $70 | $289.9K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 106 | 160 | 6,020 | $30 | $276.9K |